Home » Otsuka Wins Appeal Ruling Upholding Abilify Drug Patent
Otsuka Wins Appeal Ruling Upholding Abilify Drug Patent
Otsuka Holdings’ pharmaceutical unit and partner Bristol-Myers Squibb won an appeals court ruling that will help ward off generic-drug competition to their schizophrenia drug Abilify until April 2015.
Businessweek
Businessweek
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May